JPRN-UMIN000014709
Completed
未知
Study on Parkinson's disease and related disorders with dopamine transporter ligand [C-11]PE2I - DAT PET with [C-11]PE2I in PD and related disorders
Tokyo Metropolitan Institute of Gerontology0 sites200 target enrollmentAugust 1, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients of Parkinson'
- Sponsor
- Tokyo Metropolitan Institute of Gerontology
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.The subject who has dysfunction in the liver / kidney. 2\.The subject who has abnormal findings in the central nervous system other than the target disorders. 3\.The subjects having cardiac failure. 4\.The subject with a history of a drug or food allergy. 5\.Pregnant or woman who has a chance of pregnant. 6\.The subject who was judged by the clinical investigator to be inappropriate as a participant in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Evaluation of association of Parkinsons Disease symptoms with urinary vesicles(exsomes).Health Condition 1: G20- Parkinsons diseaseCTRI/2021/06/033946DrDinesh Upadhya
Completed
Not Applicable
Research on Parkinson's disease pathogenesis based on analysis of caffeine absorption in patients with Parkinson's diseaseParkinson&#39s diseaseJPRN-UMIN000022187Department of Neurology, Juntendo University20
Not yet recruiting
Not Applicable
A Clinical study of Parkinsonâ??s disease and comparativr evaluation of two unani formulations (Combination of jadwar and ood e saleeb with majoon e jograj gogul) in its management.Health Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereHealth Condition 2: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereCTRI/2021/09/036722Department of Moalejat
Completed
Not Applicable
Study about perception of Parkinson's disease progression among patients with Parkinson's disease and physicians in JapaJPRN-UMIN000032542AbbVie GK210
Recruiting
Not Applicable
Profiling Parkinson’s diseaseParkinson's diseaseNL-OMON21445Amsterdam UMC, location VUmc1,515